×

img Accessibility Controls

Technologies Banner

All Technologies

A Gene Chip Based Predictive Biomarker for Oral Cancer Metastasis

Project Overview

A gene expression chip comprised of 34 genes that predict nodal metastatic subset of early stage oral cancer with high specificity. Will allow to detect whether or not an early stage oral tumor has nodal metastasis, help Onco Surgeon to decide whether not to do aggressive surgery.

Benefits

Will allow to detect whether or not an early stage oral tumor has nodal metastasis, This will help onco-surgeon to decide whether not to de aggresive surgery, Approxomate number of early stage oral cancer pateint would be 75,000/year
, Projeted market value would be 150cr/year(assuming an asay cost of Rs. 20,000/-)

Source

Quick Information
Thrust Areas
Medical Sciences
Focus Area
Cancer Treatment
Source Title
Output
TRL: Technology Readiness Level
Technology Development
Patent
IN201811018135
arrowtop
Latest Updates
Loading…